Showing results (1-10 of 152) with videos related to
Sort By:
Pageof 16
Cardiovascular Research|July 10, 2007
The importance of endothelin-1 for vascular dysfunction in cardiovascular diseaseFelix Böhm, John PernowBritish Journal of Pharmacology|January 12, 2002
Urotensin II evokes potent vasoconstriction in humans in vivoFelix Böhm, John PernowCardiovascular Research|February 19, 2013
Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?John Pernow, Christian JungCurrent Vascular Pharmacology|December 8, 2015
The Emerging Role of Arginase in Endothelial Dysfunction in DiabetesJohn Pernow, Christian JungLife Sciences|April 10, 2012
New perspectives on endothelin-1 in atherosclerosis and diabetes mellitusJohn Pernow, Alexey Shemyakin, Felix BöhmClinical Science (London, England : 1979)|March 1, 2002
Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosisFelix Böhm, Gunvor Ahlborg, John PernowDiabetes & Vascular Disease Research|May 19, 2016
Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunctionOskar Kövamees, Alexey Shemyakin, John PernowLife Sciences|March 11, 2014
Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery diseaseArnar Rafnsson, Alexey Shemyakin, John PernowAtherosclerosis|March 11, 2006
Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivoFelix Böhm, Magnus Settergren, John PernowPlos One|July 30, 2014
Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitusOskar Kövamees, Alexey Shemyakin, John PernowPageof 16